IBDEI0ES ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7137,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,7137,1,5,0)
 ;;=5^Mets to Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,7137,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,7138,0)
 ;;=V10.51^^55^577^56
 ;;^UTILITY(U,$J,358.3,7138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7138,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,7138,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,7138,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,7139,0)
 ;;=V10.3^^55^577^57
 ;;^UTILITY(U,$J,358.3,7139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7139,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,7139,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,7139,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,7140,0)
 ;;=V10.41^^55^577^58
 ;;^UTILITY(U,$J,358.3,7140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7140,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,7140,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,7140,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,7141,0)
 ;;=V10.05^^55^577^59
 ;;^UTILITY(U,$J,358.3,7141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7141,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,7141,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,7141,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,7142,0)
 ;;=V10.03^^55^577^60
 ;;^UTILITY(U,$J,358.3,7142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7142,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,7142,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,7142,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,7143,0)
 ;;=V10.60^^55^577^62
 ;;^UTILITY(U,$J,358.3,7143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7143,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,7143,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,7143,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,7144,0)
 ;;=V10.11^^55^577^63
 ;;^UTILITY(U,$J,358.3,7144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7144,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,7144,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,7144,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,7145,0)
 ;;=V10.79^^55^577^64
 ;;^UTILITY(U,$J,358.3,7145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7145,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,7145,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,7145,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,7146,0)
 ;;=V10.82^^55^577^65
 ;;^UTILITY(U,$J,358.3,7146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7146,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,7146,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,7146,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,7147,0)
 ;;=V10.02^^55^577^68
 ;;^UTILITY(U,$J,358.3,7147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7147,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,7147,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,7147,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,7148,0)
 ;;=V10.43^^55^577^69
 ;;^UTILITY(U,$J,358.3,7148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7148,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,7148,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,7148,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,7149,0)
 ;;=V10.46^^55^577^70
 ;;^UTILITY(U,$J,358.3,7149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7149,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,7149,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,7149,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,7150,0)
 ;;=V10.06^^55^577^71
 ;;^UTILITY(U,$J,358.3,7150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7150,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,7150,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,7150,2)
 ;;=^295208
